Latest filing published 02 Jan 2008 for Celldex Therapeutics, Inc., €144.
Insider track record
No signal scores available.
Taha Keilani: trading record in brief
Taha Keilani discloses dealings in Celldex Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 3 July 2006 to 2 January 2008, the count stands at 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 2 January 2008, the filings show a transaction worth €144 in Celldex Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Taha Keilani
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 500 shares@ US$0.425Common StockSEC:0001179110-08-000095:0
1 of 1 declaration